Abeona Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | DEF 14A: Definitive information statements
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports Second Quarter 2023 Financial Results
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Abeona Therapeutics | 8-K: Current report
Abeona Therapeutics | 8-K: Abeona Therapeutics Reports First Quarter 2023 Financial Results
Abeona Therapeutics | DEF 14A: Definitive proxy statements
No Data